Tejnaksh Health.

{
  "main_header": {
    "sid": 999962,
    "name": "Tejnaksh Health.",
    "stock_name": "Tejnaksh Health.",
    "full_name": "Tejnaksh Healthcare Ltd",
    "name_url": "stocks-analysis/tejnaksh-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "15.40",
    "chg": -0.12,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "15.52",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539428,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE030T01027",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "21.72 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tejnaksh-health-999962-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tejnaksh Healthcare Q3 FY26: Revenue Decline Deepens Amid Margin Erosion",
        "link": "https://www.marketsmojo.com/news/result-analysis/tejnaksh-healthcare-q3-fy26-revenue-decline-deepens-amid-margin-erosion-3828655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TejnakshHealthc_quaterlyResult_3828655.png",
        "date": "2026-02-09 09:49:20",
        "description": "Tejnaksh Healthcare Ltd., a Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.30 crores for Q3 FY26, marking a sharp 50.82% decline year-on-year from ₹0.61 crores in Q3 FY25. The micro-cap company, with a market capitalisation of ₹32.00 crores, witnessed its third consecutive quarter of revenue contraction, raising concerns about operational sustainability in an otherwise resilient healthcare services sector."
      },
      {
        "title": "Are Tejnaksh Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-tejnaksh-healthcare-ltd-latest-results-good-or-bad-3826899",
        "imagepath": "",
        "date": "2026-02-07 19:20:54",
        "description": "Tejnaksh Healthcare Ltd's latest financial results for the quarter ended September 2025 reveal significant operational challenges. The company reported a decline in net sales by 11.57% year-on-year, amounting to ₹2.98 crores, marking the second consecutive quarter of negative year-on-year growth. While there was a sequential improvement of 12.88% from the previous quarter, the overall revenue remains below levels achieved in comparable quarters of the prior fiscal year.\n\nThe consolidated net profit for the same quarter was ₹0.31 crores, reflecting a substantial year-on-year decline of 50.00%. This decline is indicative of the pressures faced by the company, as the operating profit margin contracted sharply to 26.17%, down 820 basis points from the previous year. The margin compression suggests that rising operational costs or pricing pressures have not been adequately offset by volume growth or efficiency g..."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3821856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TejnakshHealthc_mojoScore_3821856.png",
        "date": "2026-02-05 08:20:07",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical trend has improved from bearish to mildly bearish, prompting a reassessment of its market stance. However, fundamental weaknesses and valuation concerns continue to weigh on investor sentiment."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Stock Falls to 52-Week Low of Rs.12.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-ltd-stock-falls-to-52-week-low-of-rs1255-3805964",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TejnakshHealthc_priceRelatedfactors_3805964.png",
        "date": "2026-01-27 11:16:58",
        "description": "Tejnaksh Healthcare Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.55 on 27 Jan 2026, marking a significant milestone in the stock’s downward trajectory amid broader market weakness and company-specific performance concerns."
      },
      {
        "title": "Tejnaksh Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3781069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TejnakshHealthc_mojoScore_3781069.png",
        "date": "2026-01-05 08:11:30",
        "description": "Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 31.0, reflecting a nuanced market view that balances technical recovery against ongoing financial underperformance and valuation considerations."
      },
      {
        "title": "Tejnaksh Healthcare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tejnaksh-healthcare-ltd-is-rated-strong-sell-3770857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TejnakshHealthc_mojoScore_3770857.png",
        "date": "2025-12-26 15:13:38",
        "description": "Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Dec 2025. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Tejnaksh Health. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-tejnaksh-health-fallingrising-3757792",
        "imagepath": "",
        "date": "2025-12-13 01:11:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend Against Market Benchmarks</strong></p>\n<p>Tejnaksh Healthcare’s recent price action is part of a broader pattern of weakness. Over the past week, the stock has fallen by 6.13%, significantly underperforming the Sensex, which declined by only 0.52% during the same period. The one-month return further emphasises this trend, with the stock dropping 11.40% while the Sensex gained 0.95%. Year-to-date figures reveal a stark contrast: Tejnaksh Healthcare has lost 33.36% of its value, whereas the Sensex has appreciated by 9.12%. This divergence extends over longer horizons as well, with the stock down 37.50% over the last year compared to the Sensex’s 4.89% gain, and a dramatic 73.32% decline over three years against the Sensex’s 37.24% rise. Even over five years, the stock rema..."
      },
      {
        "title": "Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.14.01 Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-stock-falls-to-52-week-low-amidst-continued-underperformance-3756377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TejnakshHealthc_priceRelatedfactors_3756377.png",
        "date": "2025-12-11 10:15:35",
        "description": "Tejnaksh Healthcare’s shares reached a fresh 52-week low of Rs.14.01 today, marking a significant decline amid ongoing challenges in the healthcare services sector. The stock’s performance continues to trail behind key market indices and sector benchmarks, reflecting persistent pressures on the company’s financial metrics and valuation."
      },
      {
        "title": "Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.15.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tejnaksh-healthcare-stock-falls-to-52-week-low-of-rs1515-3753647",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TejnakshHealthc_priceRelatedfactors_3753647.png",
        "date": "2025-12-09 10:35:58",
        "description": "Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.15.15 today. This marks a significant decline for the healthcare services company amid broader market fluctuations and ongoing performance concerns."
      }
    ],
    "total": 151,
    "sid": "999962",
    "stock_news_url": "https://www.marketsmojo.com/news/tejnaksh-healthcare-999962"
  },
  "announcements": [
    {
      "caption": "Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025.",
      "datetime": "07-Feb-2026",
      "details": "Please refer standalone and consolidated unaudited result for the quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On 7Th Feb 2026",
      "datetime": "07-Feb-2026",
      "details": "In continuation of our Letter dated 2th February 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday 7th February 2026 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound Block Sector: Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060 to at 4.00 pm. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31th December 2025 and took note of Limited Review Report thereon in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; The meeting of Board of Directors commenced at 4:00 pm and concluded at 6.00 pm This is for your information and record.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "18-Jan-2026",
      "details": "Respected Sir/Madam Please refer letter attached for your reference. Thanks Afrin Shaikh",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 19 Jul 23",
          "dt": "2023-07-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Tejnaksh Healthcare Ltd has announced <strong>36:10</strong> bonus issue, ex-date: 26 Apr 18",
          "dt": "2018-04-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Tejnaksh Healthcare Q3 FY26: Revenue Decline Deepens Amid Margin Erosion

2026-02-09 09:49:20

Tejnaksh Healthcare Ltd., a Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.30 crores for Q3 FY26, marking a sharp 50.82% decline year-on-year from ₹0.61 crores in Q3 FY25. The micro-cap company, with a market capitalisation of ₹32.00 crores, witnessed its third consecutive quarter of revenue contraction, raising concerns about operational sustainability in an otherwise resilient healthcare services sector.

Read full news article

Are Tejnaksh Healthcare Ltd latest results good or bad?

2026-02-07 19:20:54

Tejnaksh Healthcare Ltd's latest financial results for the quarter ended September 2025 reveal significant operational challenges. The company reported a decline in net sales by 11.57% year-on-year, amounting to ₹2.98 crores, marking the second consecutive quarter of negative year-on-year growth. While there was a sequential improvement of 12.88% from the previous quarter, the overall revenue remains below levels achieved in comparable quarters of the prior fiscal year. The consolidated net profit for the same quarter was ₹0.31 crores, reflecting a substantial year-on-year decline of 50.00%. This decline is indicative of the pressures faced by the company, as the operating profit margin contracted sharply to 26.17%, down 820 basis points from the previous year. The margin compression suggests that rising operational costs or pricing pressures have not been adequately offset by volume growth or efficiency g...

Read full news article

Tejnaksh Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-02-05 08:20:07

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical trend has improved from bearish to mildly bearish, prompting a reassessment of its market stance. However, fundamental weaknesses and valuation concerns continue to weigh on investor sentiment.

Read full news article

Tejnaksh Healthcare Ltd Stock Falls to 52-Week Low of Rs.12.55

2026-01-27 11:16:58

Tejnaksh Healthcare Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.55 on 27 Jan 2026, marking a significant milestone in the stock’s downward trajectory amid broader market weakness and company-specific performance concerns.

Read full news article

Tejnaksh Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-01-05 08:11:30

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 31.0, reflecting a nuanced market view that balances technical recovery against ongoing financial underperformance and valuation considerations.

Read full news article

Tejnaksh Healthcare Ltd is Rated Strong Sell

2025-12-26 15:13:38

Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Dec 2025. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Why is Tejnaksh Health. falling/rising?

2025-12-13 01:11:42

Persistent Downtrend Against Market Benchmarks

Tejnaksh Healthcare’s recent price action is part of a broader pattern of weakness. Over the past week, the stock has fallen by 6.13%, significantly underperforming the Sensex, which declined by only 0.52% during the same period. The one-month return further emphasises this trend, with the stock dropping 11.40% while the Sensex gained 0.95%. Year-to-date figures reveal a stark contrast: Tejnaksh Healthcare has lost 33.36% of its value, whereas the Sensex has appreciated by 9.12%. This divergence extends over longer horizons as well, with the stock down 37.50% over the last year compared to the Sensex’s 4.89% gain, and a dramatic 73.32% decline over three years against the Sensex’s 37.24% rise. Even over five years, the stock rema...

Read full news article

Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.14.01 Amidst Prolonged Underperformance

2025-12-11 10:15:35

Tejnaksh Healthcare’s shares reached a fresh 52-week low of Rs.14.01 today, marking a significant decline amid ongoing challenges in the healthcare services sector. The stock’s performance continues to trail behind key market indices and sector benchmarks, reflecting persistent pressures on the company’s financial metrics and valuation.

Read full news article

Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.15.15

2025-12-09 10:35:58

Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.15.15 today. This marks a significant decline for the healthcare services company amid broader market fluctuations and ongoing performance concerns.

Read full news article

View All News